Literature DB >> 9217925

Engineering herpes simplex virus vectors for human gene therapy.

J C Glorioso1, W F Goins, M C Schmidt, T Oligino, D M Krisky, P C Marconi, J D Cavalcoli, R Ramakrishnan, P L Poliani, D J Fink.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9217925

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  5 in total

Review 1.  Virus-based gene delivery systems.

Authors:  Cathryn Mah; Barry J Byrne; Terence R Flotte
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Gene therapy and wound healing.

Authors:  Sabine A Eming; Thomas Krieg; Jeffrey M Davidson
Journal:  Clin Dermatol       Date:  2007 Jan-Feb       Impact factor: 3.541

3.  Infection and establishment of latency in the dog brain after direct inoculation of a nonpathogenic strain of herpes simplex virus-1.

Authors:  S L Springer; C H Vite; A C Polesky; S Kesari; N W Fraser; J H Wolfe
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

4.  Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors.

Authors:  Misaki Wayengera
Journal:  Theor Biol Med Model       Date:  2011-06-24       Impact factor: 2.432

Review 5.  Gene transfer strategies in tissue engineering.

Authors:  Oliver Bleiziffer; Elof Eriksson; Feng Yao; Raymund E Horch; Ulrich Kneser
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.